This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Keytruda® in Non-small Cell Lung Cancer (BENITO Study) | MicrobiomeTrials
← Back to trials NCT06687369
A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Keytruda® in Non-small Cell Lung Cancer (BENITO Study) Recruiting PHASE3 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2024-12-30Est. Completion: 2026-08-31
Enrollment target: 726 participantsLocations Site 101001, Yerevan, Armenia Site 101002, Yerevan, Armenia Site 101003, Yerevan, Armenia Site 101004, Yerevan, Armenia Site 103001, Sarajevo, Bosnia and Herzegovina Site 103002, Tuzla, Bosnia and Herzegovina Site 103003, Zenica, Bosnia and Herzegovina Site 301014, Barretos, Brazil Site 301026, Belém, Brazil Site 301002, Belo Horizonte, Brazil Site 301023, Bento Gonçalves, Brazil Site 301006, Blumenau, Brazil Site 301019, Caxias do Sul, Brazil Site 301015, Curitiba, Brazil Site 301028, Curitiba, Brazil Site 301024, Florianópolis, Brazil Site 301010, Fortaleza, Brazil Site 301011, Ijuí, Brazil Site 301008, Itajaí, Brazil Site 301012, Jaú, Brazil Site 301018, Natal, Brazil Site 301003, Porto Alegre, Brazil Other microbiome trials you might be interested in Epidermal Growth Factor Epidermal Growth Factor Receptor Epidermal Growth Factor Receptor Gene Mutation Non Small Cell Non Small Cell Lung Non Small Cell Lung Cancer Head and Neck Head and Neck Cancer Head and Neck Cancers Head and Neck Squamous Cell Cancer Head and Neck Squamous Cell Carcinoma Head and Neck Squamous Cell Carcinoma HNSCC NSCLC (Non-small Cell Lung Cancer) HNSCC EGFR
A phase 1 study to determine the safety, tolerability, PK, PD, and preliminary anti-tumor activity of ascending doses of…
Site 301005, Porto Alegre, Brazil
Site 301007, Porto Alegre, Brazil
Site 301016, Porto Alegre, Brazil
Site 301022, Recife, Brazil
Site 301009, Rio de Janeiro, Brazil
Site 301020, Santo André, Brazil
Site 301001, São José do Rio Preto, Brazil
Site 108004, Batumi, Georgia
Site 108005, Kutaisi, Georgia
Site 108011, Marneuli, Georgia
Site 108001, Tbilisi, Georgia
Site 108002, Tbilisi, Georgia
Site 108003, Tbilisi, Georgia
Site 108006, Tbilisi, Georgia
Site 108007, Tbilisi, Georgia
Site 108008, Tbilisi, Georgia
Site 108009, Tbilisi, Georgia
Site 108010, Tbilisi, Georgia
Site 108012, Tbilisi, Georgia
Site 110006, Athens, Greece
Site 110003, Kifissia, Greece
Site 110004, Larissa, Greece
Site 110009, Pátrai, Greece
Site 110001, Thessaloniki, Greece
Site 110002, Thessaloniki, Greece
Site 110005, Thessaloniki, Greece
Site 110008, Thessaloniki, Greece
Site 110010, Volos, Greece
Site 113012, Brescia, Italy
Site 113010, Cremona, Italy
Site 113007, Genova, Italy
Site 113011, Lecce, Italy
Site 113009, Meldola, Italy
Site 113001, Pavia, Italy
Site 113003, Roma, Italy
Site 113006, Roma, Italy
Site 113005, Siena, Italy
Site 113008, Torino, Italy
Site 207002, Hakodate-shi, Japan
Site 207012, Okayama, Japan
Site 207010, Shinagawa-Ku, Japan
Site 207001, Shizuoka, Japan
Site 114001, Amman, Jordan
Site 114002, Amman, Jordan
Site 114003, Amman, Jordan
Site 114004, Amman, Jordan
Site 114005, Amman, Jordan
Site 114007, Amman, Jordan
Site 114006, Irbid, Jordan
Site 202001, Cheras, Malaysia
Site 202002, Kota Bharu, Malaysia
Site 202003, Kuala Selangor, Malaysia
Research site 116001, Chisinau, Moldova
Site 304001, Panama City, Panama
Site 304002, Panama City, Panama
Site 304003, Panama City, Panama
Site 203006, Bacolod City, Philippines
Site 203003, Baguio City, Philippines
Site 203004, Iloilo City, Philippines
Site 203009, Iloilo City, Philippines
Site 203005, Makati City, Philippines
Site 203007, Manila, Philippines
Site 203002, Quezon City, Philippines
Site 118004, Katowice, Poland
Site 118001, Lodz, Poland
Site 118005, Lublin, Poland
Site 118002, Prabuty, Poland
Site 118003, Słupsk, Poland
Site 119001, Lisbon, Portugal
Site 119002, Matosinhos Municipality, Portugal
Site 119003, Porto, Portugal
Site 120001, Cluj-Napoca, Romania
Site 120003, Craiova, Romania
Site 120004, Craiova, Romania
Site 120006, Floreşti, Romania
Site 120005, Timișoara, Romania
Site 121001, Belgrade, Serbia
Site 121002, Belgrade, Serbia
Site 121004, Kamenitz, Serbia
Site 121003, Kragujevac, Serbia
Site 121005, Užice, Serbia
Site 122003, Bardejov, Slovakia
Site 122001, Bratislava, Slovakia
Site 122002, Partizánske, Slovakia
Site 123005, Johannesburg, South Africa
Site 123006, Johannesburg, South Africa
Site 123007, Kraaifontein, South Africa
Site 123004, KwaZulu, South Africa
Site 123002, Port Elizabeth, South Africa
Site 123001, Pretoria, South Africa
Site 123003, Pretoria, South Africa
Site 204005, Busan, South Korea
Site 204004, Gyeonggi-do, South Korea
Site 204006, Gyeonggi-do, South Korea
Site 204001, Incheon, South Korea
Site 204002, Seoul, South Korea
Site 204007, Seoul, South Korea
Site 124006, A Coruña, Spain
Site 124002, Barcelona, Spain
Site 124013, Barcelona, Spain
Site 124007, Madrid, Spain
Site 124009, Madrid, Spain
Site 124011, Madrid, Spain
Site 124012, Madrid, Spain
Site 124008, Málaga, Spain
Site 124016, Murcia, Spain
Site 124003, Oviedo, Spain
Site 124001, Palma de Mallorca, Spain
Site 124014, Pontevedra, Spain
Site 124005, Sant Joan Despí, Spain
Site 124010, Santiago de Compostela, Spain
Site 124004, Seville, Spain
Site 124015, Valencia, Spain
Site 205003, Kaohsiung City, Taiwan
Site 205009, Kaohsiung City, Taiwan
Site 205004, Liuying, Taiwan
Site 205002, Taichung, Taiwan
Site 205008, Taichung, Taiwan
Site 205005, Tainan, Taiwan
Site 205006, Taipei, Taiwan
Site 205007, Taipei, Taiwan
Site 206004, Bangkok, Thailand
Site 206005, Bangkok, Thailand
Site 206001, Chiang Mai, Thailand
Site 206007, Chiang Rai, Thailand
Site 206003, Khon Kaen, Thailand
Site 206002, Nakhon Nayok, Thailand
Site 206006, Songkhla, Thailand
Site 112002, Aryanah, Tunisia
Site 112003, Aryanah, Tunisia
Site 112004, Aryanah, Tunisia
Site 112001, Sfax, Tunisia
Site 112005, Tunis, Tunisia
Site 125017, Adana, Turkey (Türkiye)
Site 125006, Alanya, Turkey (Türkiye)
Site 125001, Ankara, Turkey (Türkiye)
Site 125002, Ankara, Turkey (Türkiye)
Site 125004, Ankara, Turkey (Türkiye)
Site 125008, Ankara, Turkey (Türkiye)
Site 125009, Ankara, Turkey (Türkiye)
Site 125019, Ankara, Turkey (Türkiye)
Site 125003, Istanbul, Turkey (Türkiye)
Site 125010, Istanbul, Turkey (Türkiye)
Site 125011, Istanbul, Turkey (Türkiye)
Site 125012, Istanbul, Turkey (Türkiye)
Site 125018, Istanbul, Turkey (Türkiye)
Site 125015, Izmir, Turkey (Türkiye)
Site 125023, Sakarya, Turkey (Türkiye)
Site 125013, Samsun, Turkey (Türkiye)
Site 125007, Tekirdağ, Turkey (Türkiye)
Site 125014, Yüreğir, Turkey (Türkiye) Los Angeles, United States
Est. completion Jul 2029
Advanced Lung Non-Squamous Non-Small Cell Carcinoma Metastatic Lung Non-Squamous Non-Small Cell Carcinoma Recurrent Lung Non-Squamous Non-Small Cell Carcinoma Stage IIIB Lung Cancer AJCC v8 Stage IV Lung Cancer AJCC v8
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatm…
Anchorage, United States Est. completion Dec 31, 2026